Mylan’s EpiPen caught the full force of drug price outrage because it was the perfect target, not because it was the only one By: MarketWatch August 31, 2016 at 11:45 AM EDT Plenty of other drug companies have been raising their prices. Read More >> Related Stocks: Adamis Pharmaceuticl Mylan Sanofi-Aventis S.A. ADR Teva Pharmaceutical Industries ADR